GuideNephrology

Clinical outcomes in CKD with eGFR < 30 (CKD-PC): kidney replacement, cardiovascular event and death

Reading sheet on the CKD Prognosis Consortium models estimating at 2 and 4 years the probability and sequence of kidney replacement therapy, cardiovascular events and death.

Updated 3 November 2026

When to use it

Adults with CKD and eGFR < 30 ml/min/1.73 m² not on dialysis, to give a comprehensive prognosis (not only dialysis risk) and plan vascular access, transplantation or conservative care.

What it is

Models developed from 264,296 people in 30 countries with eGFR < 30 (median eGFR 24 and ACR 168 mg/g), using competing-risk regression, random-effects meta-analysis and Markov processes with Monte Carlo simulation. Hence there is no closed formula that can be reproduced here: results are obtained with the consortium's official calculator.

Keep reading in the app

  • Variables
  • What it provides
  • Limitations

Practical tip

Unlike the KFRE, it accounts for competing risks: in an older patient with cardiovascular disease, death may be more likely than dialysis.

2 more practical tips in the app.

Reference

Official source: Official CKD Prognosis Consortium calculator

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top